ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 30722 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 30722; 2) Community: the network communities that were significantly associated with the response to NSC 30722; 3) Molecule: the relationships between components within communities and NSC 30722; 4) MDR: the compounds that were significantly associated with the NSC 30722.

NSC Compound Enrichment Correlation
NSC 638265 Null 0.00626555836518792 0.36274164
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00626555836518792 0.49943636
NSC 668257 2,4(1H,3H)-Pyrimidinedione, 1-[[2-(4-chlorophenyl)- tetrahydro-4-methylene-5-oxo-2-furanyl]methyl]-5-methyl- 0.00626555836518792 0.53487531
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.00627320055153809 0.53319961
NSC 625731 Null 0.00627320055153809 0.38978139
NSC 630606 1-Piperidinecarboxylic acid, 3,5-bis(phenylmethylene)- 4-oxo-, 4-methylphenyl ester 0.00627320055153809 0.25408751
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00627320055153809 0.69166576
NSC 644651 Null 0.00627320055153809 0.49901483
NSC 661832 Null 0.00627320055153809 0.28197536
NSC 664271 Null 0.00627320055153809 0.59972007
Total:120  Current:23    [First] [Prev] [Next] [Last]